Research Papers

25 of 1108 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.
Jo J; Hu C; Begum K; Wang W; Le TM; Agyapong S; Hanson BM; Ayele H; Lancaster C; Jahangir Alam M; Gonzales-Luna AJ; Garey KW.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Naturally Acquired Transmission-Blocking Immunity Against Different Strains of Plasmodium vivax in a Malaria-Endemic Ar…
Thongpoon S; Roobsoong W; Nguitragool W; Chotirat S; Tsuboi T; Takashima E; Cui L; Ishino T; Tachibana M; Miura K; Sattabongkot J.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Po…
Kanberg N; Grahn A; Stentoft E; Bremell D; Yilmaz A; Studahl M; Nilsson S; Schöll M; Gostner JM; Blennow K; Zetterberg H; Padmanabhan N; Cohen R; Misaghian S; Romero D; Campbell C; Mathew A; Wang M; Sigal G; Stengelin M; Edén A; Gisslén M.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy.
Adhikari EH; Lu P; Kang YJ; McDonald AR; Pruszynski JE; Bates TA; McBride SK; Trank-Greene M; Tafesse FG; Lu LL.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Profiling the Plasmodium falciparum Erythrocyte Membrane Protein 1-Specific Immununoglobulin G Response Among Ghanaian …
Oleinikov AV; Seidu Z; Oleinikov IV; Tetteh M; Lamptey H; Ofori MF; Hviid L; Lopez-Perez M.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Two Artificial Tears Outbreak-Associated Cases of Extensively Drug-Resistant Pseudomonas aeruginosa Detected Through Wh…
Sundermann AJ; Rangachar Srinivasa V; Mills EG; Griffith MP; Waggle KD; Ayres AM; Pless L; Snyder GM; Harrison LH; Van Tyne D.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A …
Leroux-Roels I; Van Ranst M; Vandermeulen C; Abeele CV; De Schrevel N; Salaun B; Verheust C; David MP; Kotb S; Hulstrøm V.
J Infect Dis (Unknown)
Published: 2024
5/6 Transparent
Data Registered Funding Declared
Primary Exposure to SARS-CoV-2 via Infection or Vaccination Determines Mucosal Antibody-Dependent ACE2 Binding Inhibiti…
Fröberg J; Koomen VJCH; van der Gaast-de Jongh CE; Philipsen R; GeurtsvanKessel CH; de Vries RD; Baas MC; van der Molen RG; de Jonge MI; Hilbrands LB; Huynen MA; Diavatopoulos DA.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia.
Grant LR; Begier E; Theilacker C; Barry R; Hall-Murray C; Yan Q; Pope V; Pride MW; Jodar L; Gessner BD.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria.
Balanza N; Francis CK; Crowley VM; Weckman AM; Zhong K; Baro B; Varo R; Bassat Q; Kain KC; Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI) Study Group.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Human Papillomavirus Concordance Between Parents and Their Newborn Offspring: Results From the Finnish Family Human Pap…
Suominen NT; Luukkaala TH; Laprise C; Haataja MA; Grénman SE; Syrjänen SM; Louvanto K.
J Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides d…
Remich S; Kitchin N; Peterson J; Li P; Pride MW; Brock L; Anderson AS; Gruber WC; Jansen KU; Lockhart SP; Webber C.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus I…
Chou S; Alain S; Cervera C; Chemaly RF; Kotton CN; Lundgren J; Papanicolaou GA; Pereira MR; Wu JJ; Murray RA; Buss NE; Fournier M.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Within-Host Rhinovirus Evolution in Upper and Lower Respiratory Tract Highlights Capsid Variability and Mutation-Indepe…
Makhsous N; Goya S; Avendaño CC; Rupp J; Kuypers J; Jerome KR; Boeckh M; Waghmare A; Greninger AL.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Pha…
Sáez-Llorens X; Norero X; Mussi-Pinhata MM; Luciani K; de la Cueva IS; Díez-Domingo J; Lopez-Medina E; Epalza C; Brzostek J; Szymański H; Boucher FD; Cetin BS; De Leon T; Dinleyici EC; Gabriel MÁM; Ince T; Macias-Parra M; Langley JM; Martinón-Torres F; Rämet M; Kuchar E; Pinto J; Puthanakit T; Baquero-Artigao F; Gattinara GC; Arribas JMM; Ramos Amador JT; Szenborn L; Tapiero B; Anderson EJ; Campbell JD; Faust SN; Nikic V; Zhou Y; Pu W; Friel D; Dieussaert I; Lopez AG; McPhee R; Stoszek SK; Vanhoutte N.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, …
Comeaux CA; Bart S; Bastian AR; Klyashtornyy V; De Paepe E; Omoruyi E; van der Fits L; van Heesbeen R; Heijnen E; Callendret B; Sadoff J.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Accumulation of Immunity in Heavy-Tailed Sexual Contact Networks Shapes Mpox Outbreak Sizes.
Murayama H; Pearson CAB; Abbott S; Miura F; Jung SM; Fearon E; Funk S; Endo A.
J Infect Dis (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
Genomic Heterogeneity of Cryptosporidium parvum Isolates From Children in Bangladesh: Implications for Parasite Biology…
Carey M; Arju T; Cotton JA; Alam M; Kabir M; Faruque ASG; Haque R; Petri WA; Gilchrist CA.
J Infect Dis (Unknown)
Published: 2023
6/6 Transparent
Data Code Registered Funding Declared
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.
Paraskevis D; Gkova M; Mellou K; Gerolymatos G; Psalida N; Gkolfinopoulou K; Kostaki EG; Loukides S; Kotanidou A; Skoutelis A; Thiraios E; Saroglou G; Zografopoulos D; Filippou D; Mossialos E; Zaoutis T; Gaga M; Tsiodras S; Antoniadou A.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathoge…
McChalicher CWJ; Lombardo MJ; Khanna S; McKenzie GJ; Halvorsen EM; Almomani S; Schuster B; Hasson BR; McGovern BH; Ege DS; Auniņš JG.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future.
Antinori A; Bausch-Jurken M.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Tra…
Subramanian V.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Foreword: Preventing COVID-19 Among the Immunocompromised Population.
Willicombe M.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseas…
Finckh A; Ciurea A; Raptis CE; Rubbert-Roth A.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Human Blood Fluke, Schistosoma mansoni, Harbors Bacteria Throughout the Parasite's Life Cycle.
Formenti F; Cortés A; Deiana M; Salter S; Parkhill J; Berriman M; Rinaldi G; Cantacessi C.
J Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared